External Automatic Glaucoma Laser (EAGLE) for the first-line glaucoma treatment: Commercial prototype development and validation

Project Information

GLAUrious

Grant agreement ID: 720274

DOI 10.3030/720274

Project closed

EC signature date 25 August 2016

Start date 1 September 2016

End date 29 February 2020

Funded under

• Horizon 2020 Framework Programme

Total cost € 4 036 138,25

EU contribution € 2 480 275,00

Coordinated by

THE QUEEN'S UNIVERSITY OF BELFAST
United Kingdom

Deliverables

Websites, patent fillings, videos etc. (3)

Public website
Publication of at least five communicative press releases/papers/newsletters regarding the project results
Participation in at least five conferences

Documents, reports (10)

Report on planned communication activities
Report on ISO accreditation readiness
Interim report 2 of patients' recruitment, study implementation and clinical trial monitoring

Interim reports of patients' recruitment, study implementation and clinical trial monitoring

Report the final primary and secondary endpoints results assessments of FIH study

Report the final primary and secondary endpoints results assessments of FIH study

Report on clinicians workshop
Quality control plan
Finalized clinical protocol and investigator brochure submitted
Interim report 1 of patients' recruitment, study implementation and clinical trial monitoring

Interim reports of patients' recruitment, study implementation and clinical trial monitoring

Updates to the risk mitigation strategy
Report on study initiation and training of clinical sites

Demonstrators, pilots, prototypes (1)

Demonstrational prototypes produced

Other (1)

Report on DHF draft ready towards CE submission